China’s major nutrition brands and suppliers appear to have recovered from the manufacturing and supply chain impact of COVID-19 after reporting better than expected Q3 financials.
In this round-up of industry developments in China, we will look at beauty and nutrition consumption trends, how the country has become Asia’s probiotic powerhouse, and a new scientific research project linked to COVID-19.
India’s government and an industry organisation are coming together to help equip nutraceutical start-ups with new, advanced technologies to grow their business both at home and abroad.
Nestle Health Science has launched China’s first ready-to-drink protein-based total nutrition Foods for Special Medical Purposes (FSMPs) for undernourished individuals.
Experts have weighed in on the importance of educating consumers on the concept of healthy ageing, and upcoming innovations in ingredients and delivery formats to drive the concept in the rapidly ageing Asia-Pacific region.
UK-based Vitmedics, winner of the NutraIngredients-Asia Awards 2020 in the personalised nutrition category, is looking to roll out its platform and technology into Australia and New Zealand.
The third NutraIngredients-Asia Awards held last Tuesday (September 22) saw 39 finalists vying for 13 award categories. Take a look at the winners of the Special Award category.
Hyderabad-based Pulsepharma is setting its sights on major markets such as the US, Europe, South East Asia, and Africa for its nano vitamin D3 products.
Probiotics supplementation has shown to reduce the amount of bile acids – an important component of nutrition – in the gastric residuals of extremely pre-term babies, according to an RCT from Australia.
CBD supplements for general sale are unlikely to be on the shelves in Australia any time soon, despite the country’s regulator ruling to down schedule the product.
China imported dietary supplements worth US$2bn, up 32.1%, with a new report highlighting edible bird’s nest and seal oil as categories with big growth.
MGC Pharma is registering a botanical and vitamin supplement that is currently being trialled on COVID-19 patients for sale in Slovenia, while the long-term goal is to launch it as a pharmaceutical product.
Nutra firms preparing to meet Australia’s Therapeutic Goods Administration (TGA) new health claim rules should follow a four-pronged approach to ensure they meet the looming deadline.